These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 870679)

  • 21. Differential effects of amphetamine transport vs. dopamine reverse transport on particulate PKC activity in striatal synaptoneurosomes.
    Giambalvo CT
    Synapse; 2003 Aug; 49(2):125-33. PubMed ID: 12740868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum.
    Bowyer JF; Tank AW; Newport GD; Slikker W; Ali SF; Holson RR
    J Pharmacol Exp Ther; 1992 Feb; 260(2):817-24. PubMed ID: 1346646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The presence of the type A form of monoamine oxidase within nigrostriatal dopamine-containing neurons.
    Demarest KT; Smith DJ; Azzaro AJ
    J Pharmacol Exp Ther; 1980 Nov; 215(2):461-8. PubMed ID: 7441510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of dopamine synthesis inhibition by dopamine autoreceptor activation in striatal synaptosomes with in vivo reserpine administration.
    Tissari AH; Lillgäls MS
    J Neurochem; 1993 Jul; 61(1):231-8. PubMed ID: 8099951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine synthesis in rat brain striatal synaptosomes. II. Dibutyryl cyclic adenosine 3':5'-monophosphoric acid and 6-methyltetrahydropterine-induced synthesis increases without an increase in endogenous dopamine release.
    Patrick RL; Barchas JD
    J Pharmacol Exp Ther; 1976 Apr; 197(1):97-104. PubMed ID: 177758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amphetamine- and phenylethylamine-induced alterations in dopamine synthesis regulation in rat brain striatal synaptosomes.
    Roberts MM; Patrick RL
    J Pharmacol Exp Ther; 1979 Apr; 209(1):104-10. PubMed ID: 430370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release.
    Hoffmann IS; Talmaciu RK; Cubeddu LX
    J Pharmacol Exp Ther; 1986 Aug; 238(2):437-46. PubMed ID: 2942676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synaptosomal dopamine autoreceptors: sensitivity changes after in vitro and in vivo treatments.
    Tissari AH
    Pharmacol Res Commun; 1988 Nov; 20(11):1001-11. PubMed ID: 2853876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo.
    Galloway MP; Wolf ME; Roth RH
    J Pharmacol Exp Ther; 1986 Mar; 236(3):689-98. PubMed ID: 3081705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lithium attenuates dopamine depleting effects of reserpine and tetrabenazine but not that of alpha methyl-p-tyrosine.
    Reches A; Hassan MN; Jackson VR; Fahn S
    Life Sci; 1983 Jul; 33(2):157-60. PubMed ID: 6865653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of alpha-methyldopa on dopamine synthesis and release in rat striatum in vitro.
    Uretsky NJ; Chase GJ; Lorenzo AV
    J Pharmacol Exp Ther; 1975 Apr; 193(1):73-87. PubMed ID: 237116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The MAO-B inhibitor deprenyl reduces the oral tremor and the dopamine depletion induced by the VMAT-2 inhibitor tetrabenazine.
    Podurgiel SJ; Yohn SE; Dortche K; Correa M; Salamone JD
    Behav Brain Res; 2016 Feb; 298(Pt B):188-91. PubMed ID: 26590367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of dopamine synthesis in rat brain striatal synaptosomes.
    Patrick RL; Snyder TE; Barchas JD
    Mol Pharmacol; 1975 Sep; 11(5):621-31. PubMed ID: 1177870
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibitory effects of amphetamine on potassium-stimulated release of [3H]dopamine from striatal slices and synaptosomes.
    Bowyer JF; Masserano JM; Weiner N
    J Pharmacol Exp Ther; 1987 Jan; 240(1):177-86. PubMed ID: 3100768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of tetrabenazine on methamphetamine-induced hyperactivity in mice are dependent on order and time-course of administration.
    Kuribara H
    Pharmacol Biochem Behav; 1997 Jan; 56(1):9-14. PubMed ID: 8981603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tetrabenazine-induced depletion of brain monoamines: characterization and interaction with selected antidepressants.
    Pettibone DJ; Totaro JA; Pflueger AB
    Eur J Pharmacol; 1984 Jul; 102(3-4):425-30. PubMed ID: 6489435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential interactions of phencyclidine with tetrabenazine and reserpine affecting intraneuronal dopamine.
    Bagchi SP
    Biochem Pharmacol; 1983 Oct; 32(19):2851-6. PubMed ID: 6626259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The accumulation of dopamine into striatal synaptosomes, and its inhibition: comparison of crude, partially purified and purified synaptosomal preparations.
    Tuomisto J; Tuomisto L
    Med Biol; 1979 Aug; 57(4):238-45. PubMed ID: 513880
    [No Abstract]   [Full Text] [Related]  

  • 39. Dopamine synthesis in synaptosomes: relation of autoreceptor functioning to pH, membrane depolarization, and intrasynaptosomal dopamine content.
    Saller CF; Salama AI
    J Neurochem; 1984 Sep; 43(3):675-88. PubMed ID: 6747629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synaptosomal dopamine from phenylalanine in brain: effects of some dopaminergic agents.
    Bagchi SP; Smith TM
    Res Commun Chem Pathol Pharmacol; 1979 Dec; 26(3):447-58. PubMed ID: 523781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.